Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website

Halozyme Therapeutics

Halozyme Therapeutics reported $52.24M in Pre-Tax Profit for its fiscal quarter ending in March of 2023.

Pre Tax Profit Change
Acadia Pharmaceuticals ACAD:US USD -44939000 4.05M
Agios Pharmaceuticals AGIO:US USD -81018000 117.54M
Alnylam Pharmaceuticals ALNY:US USD -172362000 34.66M
Amarin AMRN:US USD -14496000 7.72M
Baxter International BAX:US USD 387M 147M
Cara Therapeutics CARA:US USD -26665000 3.67M
Esperion Therapeutics ESPR:US USD -61719000 6.23M
Halozyme Therapeutics HALO:US USD 52.24M 18.55M
Immunogen IMGN:US USD -41014000 16.78M
Intercept Pharmaceuticals ICPT:US USD -31881000 14.34M
Intra Cellular Therapies ITCI:US USD -44043000 17K
Intrexon XON:US USD -22789000 621K
Ionis Pharmaceuticals IONS:US USD -113000000 81M
MannKind MNKD:US USD -9795000 8.15M
Minerva Neurosciences NERV:US USD -6970000 244K
Nektar Therapeutics NKTR:US USD -137081000 80.54M
Peregrine Pharmaceuticals PPHM:US USD 2.53M 5.77M
United Therapeutics UTHR:US USD 291.9M 113.1M